Targeting Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2 Sensitizes Anti-PD-L1 Immunotherapy of Pancreatic Ductal Adenocarcinoma

0
159
Proteomic analysis was performed to compare changes of Panc02 cell lines cultured with conditional medium and leucine rich repeat kinase 2 was identified as a differential gene.
[Molecular Therapy]
Full ArticleGraphical Abstract